2012 Fiscal Year Final Research Report
CEACAM-1 promotes lymphangiogenesis and angiogenesis in the inoculated mouse mammary carcinomas.
| Project/Area Number |
22591446
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Osaka Medical College |
|---|
Principal Investigator |
ITO Yuko 大阪医科大学, 医学部, 講師 (40148432)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
OTSUKI Yoshinori 大阪医科大学, 医学部, 教授 (50140166)
SHIBATA Masa-aki 大阪保健医療大学, 保健医療部, 教授 (10319543)
MORIMOTO Junji 大阪医科大学, 医学部, 講師 (90145889)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Keywords | 乳癌 / リンパ管新生 / 血管新生 / CEACAM-1 / Microvesicles / 癌治療 |
|---|
| Research Abstract |
In a highly metastatic mouse mammary carcinoma model which express VEGF-C strongly, CEACAM-1 promots angiogenesis and lymphangiogenesis. I t was suggested that the blood capillaries which expressed CEACAM-1 on the endothelium were remodeled into lymphatic capillaries. Moreover, shedding vesicles containing CEACAM-1 were released from mouse mammary carcinoma cells and may be engulfed byendothelial cells of blood capillaries.
|
